Detected residual venous thrombi and catheter-directed management of intermediate-risk pulmonary thromboembolism
-
By
-
Samuel N. Heyman
-
David Leibowitz
-
Eyal Herzog
-
June 5, 2026
-
Clinical Scorecard: Management of Intermediate-Risk Pulmonary Embolism with Catheter-Directed Therapy for Residual Venous Thrombi
At a Glance
| Category | Detail |
|---|
| Condition | Intermediate-Risk Pulmonary Embolism |
| Key Mechanisms | Retained clots lead to recurrent thromboembolism and increased mortality post PE. |
| Target Population | Patients with intermediate-high risk PE and potentially intermediate-low risk patients with retained venous clots. |
| Care Setting | Hospital settings with access to catheter-directed interventions. |
Key Highlights
- Retained venous thrombi are associated with increased mortality post PE.
- Current guidelines restrict catheter-directed interventions to hemodynamically unstable and intermediate-high risk patients.
- Detection of retained clots may influence treatment decisions.
- Presence of retained DVT significantly predicts 30-day mortality.
- Proposed evaluation of retained clots in intermediate-low risk patients.
Guideline-Based Recommendations
Diagnosis
- Evaluate cardiac echo and troponin levels to classify risk in PE patients.
- Consider ultrasound to detect retained venous thrombi.
Management
- Catheter-directed interventions are recommended for hemodynamically unstable and intermediate-high risk patients.
- Consider extending catheter-directed interventions to intermediate-low risk patients with retained clots.
Monitoring & Follow-up
- Monitor for signs of recurrent thromboembolic events and RV dysfunction.
Risks
- Retained venous thrombi increase the risk of mortality and recurrent PE.
Patient & Prescribing Data
Patients recovering from pulmonary embolism with or without retained venous thrombi.
Persistent pulmonary hypertension may underlie susceptibility to lethal events upon repeated embolic events.
Clinical Best Practices
- Assess for retained venous thrombi in patients with PE to guide treatment.
- Monitor RV function and troponin levels in PE patients.
Related Resources & Content
